Variants in genes affecting cysteine metabolism, glutathione synthesis, and oxidative stress response can inform discussions with your provider about whether glutathione supplementation aligns with your genetic background
Others use 1%, which is actually enough to move the needle on skin and hair
In Phase 2 obesity trials, retatrutide produced approximately 24% mean body-weight reduction at 48 weeks at the 12 mg dose the largest weight-loss effect reported for any GLP-1-class compound to date
February 2, 2026: FDA Posts Updated Safety Label for Mounjaro On January 20, 2026, the FDA posted an updated safety/warning label with new patient information for those taking Mounjaro (tirzepatide)
Journal of Medicinal Chemistry, 2015, 58(18):7370.DOI:10.1021/acs.jmedchem.5b00726